Displaying 51 - 60 of 405 results for "闽财行〔2023〕6号"
-
Appropriate medication use in aged residential care: Optimising the use of antibiotics, antipsychotics and fentanyl | Ngā rongoā tika mā ngā kaumātua/kuia: Kia tika te whāngai atu o ngā rongoā paturopi
This report focuses on optimising the use of particular medicines in aged residential care. It was originally published in May 2020 and updated in June 2022.
-
Mental health and addiction quality improvement programme evaluation 2023
An evaluation of the mental health and addiction quality improvement programme, undertaken by social research company Litmus in late 2023.
-
Executive summary: A window on quality 2022 (Part 2) | Whakarāpopototanga matua: He tirohanga kounga 2021 (Wāhanga 2)
In this report, we use perspectives from respondents in the health and disability sector and hard data to continue important lines of enquiry we began in A window on quality 2021: COVID-19 and its impacts on our broader health system (Part 1).
- 2020 evidence base
-
Healthcare-associated Staphylococcus aureus bacteraemia: Te Whatu Ora – Health New Zealand districts
This report summarises results from the first 12 months of continuous ongoing surveillance of healthcare-associated Staphylococcus aureus bacteraemia, across all districts of Te Whatu Ora – Health New Zealand, from 1 July 2022 to 30 June 2023.
-
Healthcare-associated Staphylococcus aureus bacteraemia: Te Whatu Ora – Health New Zealand districts 2024
This report summarises results from two years of this surveillance across all districts of Te Whatu Ora | Health New Zealand, from 1 July 2022 to 30 June 2024.
- Heart failure | Manawa-hē (Frailty care guides 2023)
- Fractures | Ngā whatinga kōiwi (Frailty care guides 2023)
- Pressure injury | Whara pēhanga (Frailty care guides 2023)
- Scabies | Mate māngeongeo riha (Frailty care guides 2023)